140 related articles for article (PubMed ID: 21397675)
1. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol.
Wang XH; Cai LL; Zhang XY; Deng LY; Zheng H; Deng CY; Wen JL; Zhao X; Wei YQ; Chen LJ
Int J Pharm; 2011 May; 410(1-2):169-74. PubMed ID: 21397675
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles.
Qiu N; Cai LL; Xie D; Wang G; Wu W; Zhang Y; Song H; Yin H; Chen L
Biomed Mater; 2010 Dec; 5(6):065006. PubMed ID: 20966535
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
4. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
5. Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice.
Zheng J; Tang Y; Sun M; Zhao Y; Li Q; Zhou J; Wang Y
Pharmazie; 2013 Jan; 68(1):41-6. PubMed ID: 23444779
[TBL] [Abstract][Full Text] [Related]
6. Distribution of liposomal bifendate in liver following intravenous injection in mice.
Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
Gong C; Wei X; Wang X; Wang Y; Guo G; Mao Y; Luo F; Qian Z
Nanotechnology; 2010 May; 21(21):215103. PubMed ID: 20431208
[TBL] [Abstract][Full Text] [Related]
8. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin.
Sun Y; Zhao Y
J Nanosci Nanotechnol; 2012 Oct; 12(10):7677-84. PubMed ID: 23421127
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
13. [Micronization of magnolia bark extract by RESS as well as dissolution and pharmacokinetics evaluation].
He S; Lei ZJ; Zhang SY; Zhang ZY
Yao Xue Xue Bao; 2009 May; 44(5):532-9. PubMed ID: 19618732
[TBL] [Abstract][Full Text] [Related]
14. Development and pharmacokinetics of nimodipine-loaded liposomes.
Wang Z; Deng Y; Zhang X; Wang T; Wu F
J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
[TBL] [Abstract][Full Text] [Related]
15. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats.
Zhu CJ; Zhang JT
Chirality; 2003 Oct; 15(8):668-73. PubMed ID: 12923804
[TBL] [Abstract][Full Text] [Related]
18. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-loaded polymeric micelles with honokiol for oral delivery.
Li X; Hou X; Ding W; Cong S; Zhang Y; Chen M; Meng Y; Lei J; Liu Y; Li G
J Pharm Pharmacol; 2015 Dec; 67(12):1663-72. PubMed ID: 26454249
[TBL] [Abstract][Full Text] [Related]
20. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
